Health Care · S&P 500

Abbott Laboratories

A broad healthcare company spanning diagnostics, medical devices, nutrition, and generic drugs, strong in glucose monitoring. S&P 500 constituent. Sector: Health Care (Health Care Equipment). Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.

ABT Updated Jul 11, 2026 2 AI consumers· 1 recurring

Annual return · 2026-07-10'21+30.5%'22-20.7%'23+2.3%'24+4.8%'25+12.9%YTD-24.2%
Money in·
Abbott Laboratories~$42B
Money out·

Financials & Segments

  • Total revenue · ~$42B (FY2024)
  • Segments · Medical Devices · Diagnostics · Nutrition · Established Pharmaceuticals

Revenue from

No refined links yet.

Pays to

No refined links yet.


← All companiesMarkdown · JSON

For information only, not investment advice. Content on this site is generated by AI from verified, cross-checked sources and may contain errors.

© 2026 Willow Investments, Inc.Company value-chain data · contact@willowinvt.com